Cardiovascular Risk Associated With Ibrutinib Use in CLL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiovascular Risk Associated With Ibrutinib Use in Chronic Lymphocytic Leukemia: A Population-Based Cohort Study
J. Clin. Oncol 2021 Aug 31;[EPub Ahead of Print], H Abdel-Qadir, N Sabrie, D Leong, A Pang, PC Austin, A Prica, K Nanthakumar, O Calvillo-Argüelles, DS Lee, P ThavendiranathanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.